Predictive Value of Biological Markers for Hepatocellular Carcinoma Patients Treated with Orthotopic Liver Transplantation

Clinical Cancer Research

Volumn 10, Issue 5, 2004, Pages 1789-1795

  Fiorentino, Michelangelo ^a   Altimari, Annalisa ^a   Ravaioli, Matteo ^a   Gruppioni, Elisa ^a   Gabusi, Elena ^a   Corti, Barbara ^a   Vivarelli, Marco ^a   Bringuier, Pierre Paul ^b   Scoazec, Jean Yves ^b   Grigioni, Walter Franco ^a,c   D'Errico Grigioni, Antonia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c Istituto Oncologico Addarii   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CYCLIN DEPENDENT KINASE INHIBITOR; KI 67 ANTIGEN; PROTEIN P27; UVOMORULIN;

ADULT; ARTICLE; CANCER RECURRENCE; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THROMBOSIS;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; RECURRENCE; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 12144286673     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-1149-3     Document Type: Article

References (36)

1. Bosch, F. X., Ribes, J., and Borras, J. Epidemiology of primary liver cancer. Semin. Liver Dis., 19: 271-285, 1999.
2. Grazi, G. L., Ercolani, G., Pierangeli, F., Del Gaudio, M., Cescon, M., Cavallari, A., and Mazziotti, A. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann. Surg., 234: 71-78, 2001.
3. Schafer, D. F., and Sorrell, M. F. Hepatocellular carcinoma. Lancet, 353: 1253-1257, 1999.
4. Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., and Gennari, L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med., 334: 693-699, 1996.
5. Ercolani, G., Grazi, G. L., Ravaioli, M., Del Gaudio, M., Gardini, A., Cescon, M., Varotti, G., Cetta, F., and Cavallai, A. Liver resection for hepatocellular carcinoma on cirrhosis. Ann. Surg., 237: 536-543, 2001.
6. Bismuth, H., Majno, P. E., and Adam, R. Liver transplantation for hapatocellular carcinoma. Semin. Liver Dis., 19: 311-322, 1999.
7. Llovet, J. M., Bruix, J., Fuster, J., Castells, A., Garcia-Valdecasas, J. C., Grande, L., Franca, A., Brù, C., Navasa, M., Ayuso, M., et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastatis classification does not have prognostic power. Hepatology, 27: 1572-1577, 1998.
8. Iwatsuki, S., Dvorchik, I., Marsh, J. W., Madariaga, J. R., Carr, B., Fung, J. J., and Starzl, T. E. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J. Am. Coll. Surg., 191: 389-394, 2000.
9. Klintmalm, G. B. Liver transplantation for hepatocellular carcinoma. A registry report of the impact of tumor characteristics on outcome. Ann. Surg., 228: 479-490, 1998.
10. Yao, F. Y., Ferrel, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., and Roberts, J. P. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 33: 1394-1403, 2001.
11. Tamura, S., Kato, T., Berho, M., Misiakos, E. P., O'Brien, C., Reddy, K. R., Nery, J. R., Burke, G. W., Schiff, E. R., Miller, J., and Tzakis, A. G. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch. Surg., 136: 25-30, 2001.
12. Jonas, S., Bechstein, W. O., Steinmuller, T., Herrmann, M., Radke, C., Berg, T., Settmacher, U., and Neuhaus, P. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology, 33: 1080-1086, 2001.
13. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology, 31: 840-845, 2000.
14. Kirimlioglu, H., Dvorchick, I., Ruppert, K., Finkelstein, S., Marsh, J. W., Iwatsuki, S., Bonham, A., Carr, B., Naleskin, M., Michalopoulos, G., et al. Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology, 34: 502-510, 2001.
15. Fiorentino, M., Altimari, A., D'Errico, A., Cukor, B., Barozzi, C., Loda, M., and Grigioni, W. F. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma. Clin. Cancer Res., 6: 3966-3972, 2000.
16. Qin, L. X., and Tang, Z. Y. The prognostic molecular markers in hepatocellular carcinoma. World J. Gastroenterol., 8: 385-392, 2002.
17. Hu, T. H., Hang, C. C., Lin, P. R., Chang, H. W., Ger, L. P., Lin, Y. W., Changchien, C. S., Lee, C. M., and Tai, M. H. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/FEP1 in hepatocellular carcinoma. Cancer (Phila.), 97: 1929-1940, 2003.
18. Poon, R. T., Ng, I. O., Lau, C., Yu, W. C., Yang, Z. F., Fan, S. T. and Wong, J. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J. Clin Oncol., 20: 1775-1785, 2002.
19. D'Errico, A., Grigioni, W. F., Fiorentino, M., Baccarini, P., Grazi, G. L., and Mancini, A. M. Overexpression of p53 protein and Ki67 proliferative index in hepatocellular carcinoma: an immunohistochemical study on 109 Italian patients. Pathol. Int., 44: 682-687, 1994.
20. Kozyraki, R., Scoazec, J. Y., Flejou, J. F., D'Errico, A., Bedossa, P., Terris, B., Fiorentino, M., Bringuier, A. F., Grigioni, W. F., and Feldmann, G. Expression of cadherins and α-catenin in primary epithelial tumors of the liver. Gastroenterology, 110: 1137-1149, 1996.
21. Endo, K., Ueda, T., Ueyama, J., Ohta, T., and Terada, T. Immunoreactive E-cadherin, α-catenin, β-catenin, and γ-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum. Pathol., 31: 558-565, 2000.
22. Huang, G. T., Lee, H. S., Chen, C. H., Sheu, J. C., Chiou, L. L., and Chen, D. S. Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma. Hepato-Gastroenterology, 46: 1923-1927, 1999.
23. Matsumura, T., Makino, R., and Mitamura, K. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin. Cancer Res., 7: 594-599, 2001.
24. Inagawa, S., Itabashi, M., Adachi, S., Kawamoto, T., Hori, M., Shimazaki, J., Yoshimi, F., and Fukao, K. Expression and prognostic roles of β-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin. Cancer Res., 8: 450-456, 2002.
25. Nhieu, J. T. V., Renard, C. A., Wei, Y., Cherqui, D., Zafrani, E. S., and Buendia, M. A. Nuclear accumulation of mutated β-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am. J. Pathol., 155: 703-710, 1999.
26. Mao, T. L., Chu, J. S., Jeng, Y. M., Lai, P. L., and Hsu, H. C. Expression of mutant nuclear β-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis. J. Pathol., 193: 95-101, 2001.
27. Hsu, H. C., Jeng, Y. M., Mao, T. L., Chu, J. S., Lai, P. L., and Peng, S. Y. β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B and with favorable prognosis. Am. J. Pathol., 157: 763-770, 2000.
28. Wong, C. M., Fan, S. T., and Ng, I. O. L. β-catenin mutation and overexpression in hepatocellular carcinoma, Clinicopathologic and prognostic significance. Cancer (Phila.), 92: 136-145, 2001.
29. Craig, J. R., Peters, R. L., and Edmondson, H. A. Tumors of the liver and intrahepatic bile ducts. In: Atlas of Tumor Pathology, pp. 48-169. Washington D. C.: Armed Forces Institute of Pathology (A. F. I. P.), 1988.
30. Snedecor, G. W., and Cochran, W. G. Statistical Methods. Ames, IA: Iowa State University Press, 1990.
31. Kaplan, E. L., and Meier, P. Nonparametric estimation for incomplete observations. J. Am. Statist. Assoc., 53: 457-481, 1958.
32. Cox, D. R. Regression models and life tables (with discussion). J. R. Statist. Soc., B3: 187-220, 1972.
33. Lee, E. T. Statistical Methods for Survival Data Analysis. New York: John Wiley, 1992.
34. Huang, H., Fujii, H., Sankila, A., Mahler-Araujo, B. M., Matsuda, M., Cathomas, G., and Ohgaki, H. β-Catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am. J. Pathol., 155: 1795-1801, 1999.
35. Figueras, J., Jaurrieta, E., Valls, C., Benasco, C., Rafecas, A., Xiol, X., Fabregat, J., Casanovas, T., Torras, J., Baliellas, C., et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology, 25: 1485-1489, 1997.
36. Wei, Y., Nhieu, J. T. V., Prigent, S., Srivatanakul, P., Tiollais, P., and Buendia, M. A. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, β-catenin expression, and clinical features. Hepatology, 36: 692-701, 2002.